These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 10935889)

  • 1. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
    Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
    J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy and toxicity of VAC chemotherapy (vincristine, doxorubicin, and cyclophosphamide) in dogs with hemangiosarcoma.
    Hammer AS; Couto CG; Filppi J; Getzy D; Shank K
    J Vet Intern Med; 1991; 5(3):160-6. PubMed ID: 1920253
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of canine hemangiosarcoma: 2000 and beyond.
    Clifford CA; Mackin AJ; Henry CJ
    J Vet Intern Med; 2000; 14(5):479-85. PubMed ID: 11012108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
    Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
    J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of a novel tumor vaccine in dogs with hemangiosarcoma.
    U'Ren LW; Biller BJ; Elmslie RE; Thamm DH; Dow SW
    J Vet Intern Med; 2007; 21(1):113-20. PubMed ID: 17338158
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does thalidomide prolong survival in dogs with splenic haemangiosarcoma?
    Bray JP; Orbell G; Cave N; Munday JS
    J Small Anim Pract; 2018 Feb; 59(2):85-91. PubMed ID: 29210452
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.
    Sorenmo KU; Jeglum KA; Helfand SC
    J Vet Intern Med; 1993; 7(6):370-6. PubMed ID: 8114034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of outcome associated with subcutaneous and intramuscular hemangiosarcoma treated with adjuvant doxorubicin in dogs: 21 cases (2001-2006).
    Bulakowski EJ; Philibert JC; Siegel S; Clifford CA; Risbon R; Zivin K; Cronin KL
    J Am Vet Med Assoc; 2008 Jul; 233(1):122-8. PubMed ID: 18593321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maintenance therapy with toceranib following doxorubicin-based chemotherapy for canine splenic hemangiosarcoma.
    Gardner HL; London CA; Portela RA; Nguyen S; Rosenberg MP; Klein MK; Clifford C; Thamm DH; Vail DM; Bergman P; Crawford-Jakubiak M; Henry C; Locke J; Garrett LD
    BMC Vet Res; 2015 Jun; 11():131. PubMed ID: 26062540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epirubicin in the adjuvant treatment of splenic hemangiosarcoma in dogs: 59 cases (1997-2004).
    Kim SE; Liptak JM; Gall TT; Monteith GJ; Woods JP
    J Am Vet Med Assoc; 2007 Nov; 231(10):1550-7. PubMed ID: 18021000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
    Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
    Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and toxicity of a dose-intensified doxorubicin protocol in canine hemangiosarcoma.
    Sorenmo KU; Baez JL; Clifford CA; Mauldin E; Overley B; Skorupski K; Bachman R; Samluk M; Shofer F
    J Vet Intern Med; 2004; 18(2):209-13. PubMed ID: 15058772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doxorubicin and deracoxib adjuvant therapy for canine splenic hemangiosarcoma: a pilot study.
    Kahn SA; Mullin CM; de Lorimier LP; Burgess KE; Risbon RE; Fred RM; Drobatz K; Clifford CA
    Can Vet J; 2013 Mar; 54(3):237-42. PubMed ID: 23997259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
    Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
    J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and pharmacokinetic characteristics of intracavitary administration of pegylated liposomal encapsulated doxorubicin in dogs with splenic hemangiosarcoma.
    Sorenmo K; Samluk M; Clifford C; Baez J; Barrett JS; Poppenga R; Overley B; Skorupski K; Oberthaler K; Van Winkle T; Seiler G; Shofer F
    J Vet Intern Med; 2007; 21(6):1347-54. PubMed ID: 18196746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
    Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ
    Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
    Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
    J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: a randomized multi-institutional clinical trial.
    Vail DM; MacEwen EG; Kurzman ID; Dubielzig RR; Helfand SC; Kisseberth WC; London CA; Obradovich JE; Madewell BR; Rodriguez CO
    Clin Cancer Res; 1995 Oct; 1(10):1165-70. PubMed ID: 9815908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgery and doxorubicin in dogs with hemangiosarcoma.
    Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
    J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the anti-tumour activity of Coriolus versicolor polysaccharopeptide (I'm-Yunity) alone or in combination with doxorubicin for canine splenic hemangiosarcoma.
    Gedney A; Salah P; Mahoney JA; Krick E; Martins R; Scavello H; Lenz JA; Atherton MJ
    Vet Comp Oncol; 2022 Sep; 20(3):688-696. PubMed ID: 35442554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.